Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

JoAnn Manson, Dr.P.H., M.D.

Co-Author

This page shows the publications co-authored by JoAnn Manson and Paul Ridker.
Connection Strength

4.000
  1. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 1999 Aug 17; 100(7):713-6.
    View in: PubMed
    Score: 0.213
  2. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative. JAMA Intern Med. 2018 09 01; 178(9):1231-1240.
    View in: PubMed
    Score: 0.199
  3. Clinical utility of lipoprotein-associated phospholipase A2 for cardiovascular disease prediction in a multiethnic cohort of women. Clin Chem. 2012 Sep; 58(9):1352-63.
    View in: PubMed
    Score: 0.131
  4. Physical activity and inflammation in a multiethnic cohort of women. Med Sci Sports Exerc. 2012 Jun; 44(6):1088-96.
    View in: PubMed
    Score: 0.129
  5. Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative. Circulation. 2012 Apr 10; 125(14):1748-56, S1-11.
    View in: PubMed
    Score: 0.127
  6. Racial differences in coronary heart disease incidence and mortality. Methodologic mythology? Ann Epidemiol. 1990 Oct; 1(1):97-100.
    View in: PubMed
    Score: 0.115
  7. HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia. 2008 Feb; 51(2):267-75.
    View in: PubMed
    Score: 0.095
  8. C-reactive protein and risk of breast cancer. J Natl Cancer Inst. 2007 Jun 06; 99(11):890-4.
    View in: PubMed
    Score: 0.091
  9. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005 Dec; 28(12):2926-32.
    View in: PubMed
    Score: 0.082
  10. Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study. Thromb Haemost. 2005 Jun; 93(6):1108-16.
    View in: PubMed
    Score: 0.080
  11. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005 Mar 31; 352(13):1293-304.
    View in: PubMed
    Score: 0.078
  12. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol. 2003 Nov; 13(10):674-82.
    View in: PubMed
    Score: 0.071
  13. Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women. Am J Med. 2003 Apr 15; 114(6):438-44.
    View in: PubMed
    Score: 0.069
  14. C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol. 2003 Apr 01; 23(4):650-5.
    View in: PubMed
    Score: 0.068
  15. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002 Oct 01; 22(10):1668-73.
    View in: PubMed
    Score: 0.066
  16. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA. 2002 Aug 28; 288(8):980-7.
    View in: PubMed
    Score: 0.066
  17. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol. 2002 May 01; 89(9):1117-9.
    View in: PubMed
    Score: 0.064
  18. Is C-reactive protein specific for vascular disease in women? Ann Intern Med. 2002 Apr 02; 136(7):529-33.
    View in: PubMed
    Score: 0.064
  19. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002 Mar; 75(3):492-8.
    View in: PubMed
    Score: 0.064
  20. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women. J Am Coll Cardiol. 2001 Nov 01; 38(5):1302-6.
    View in: PubMed
    Score: 0.062
  21. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001 Jul 18; 286(3):327-34.
    View in: PubMed
    Score: 0.061
  22. Sugar-Sweetened Beverage Consumption May Modify Associations Between Genetic Variants in the CHREBP (Carbohydrate Responsive Element Binding Protein) Locus and HDL-C (High-Density Lipoprotein Cholesterol) and Triglyceride Concentrations. Circ Genom Precis Med. 2021 08; 14(4):e003288.
    View in: PubMed
    Score: 0.061
  23. Association of Plasma Branched-Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in Women. Circ Genom Precis Med. 2021 08; 14(4):e003330.
    View in: PubMed
    Score: 0.061
  24. Homocysteine Is Associated With Future Venous Thromboembolism in 2 Prospective Cohorts of Women. Arterioscler Thromb Vasc Biol. 2021 07; 41(7):2215-2224.
    View in: PubMed
    Score: 0.060
  25. Association of endogenous tissue plasminogen activator (t-PA) with clinical characteristics of the insulin resistance syndrome. J Thromb Thrombolysis. 2000 Dec; 10(3):227-31.
    View in: PubMed
    Score: 0.058
  26. Association of the Mediterranean Diet With Onset of Diabetes in the Women's Health Study. JAMA Netw Open. 2020 11 02; 3(11):e2025466.
    View in: PubMed
    Score: 0.058
  27. Plasma Placental Growth Factor Concentrations Are Elevated Well in Advance of Type 2 Diabetes Mellitus Onset: Prospective Data From the WHS. J Am Heart Assoc. 2019 08 06; 8(15):e012790.
    View in: PubMed
    Score: 0.053
  28. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA. 1999 May 19; 281(19):1817-21.
    View in: PubMed
    Score: 0.052
  29. Vasectomy and subsequent cardiovascular disease in US physicians. Contraception. 1999 Mar; 59(3):181-6.
    View in: PubMed
    Score: 0.052
  30. Comparison of Cardiovascular Risk Factors for Coronary Heart Disease and Stroke Type in Women. J Am Heart Assoc. 2018 10 02; 7(19):e007514.
    View in: PubMed
    Score: 0.050
  31. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med. 1998 Jun 15; 128(12 Pt 1):1000-3.
    View in: PubMed
    Score: 0.049
  32. Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women. Circ Genom Precis Med. 2018 04; 11(4):e002157.
    View in: PubMed
    Score: 0.048
  33. Markers of Inflammation and Incident Breast Cancer Risk in the Women's Health Study. Am J Epidemiol. 2018 04 01; 187(4):705-716.
    View in: PubMed
    Score: 0.048
  34. Association between Vitamin D Genetic Risk Score and Cancer Risk in a Large Cohort of U.S. Women. Nutrients. 2018 Jan 09; 10(1).
    View in: PubMed
    Score: 0.048
  35. Postmenopausal hormone replacement therapy and cardiovascular disease. Thromb Haemost. 1997 Jul; 78(1):770-80.
    View in: PubMed
    Score: 0.046
  36. The effect of statins on cardiovascular outcomes by smoking status: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2017 Aug; 122:105-117.
    View in: PubMed
    Score: 0.046
  37. Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality. PLoS One. 2016; 11(11):e0165615.
    View in: PubMed
    Score: 0.044
  38. Lipid biomarkers and long-term risk of cancer in the Women's Health Study. Am J Clin Nutr. 2016 06; 103(6):1397-407.
    View in: PubMed
    Score: 0.042
  39. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group. Ann Epidemiol. 1995 Jul; 5(4):261-9.
    View in: PubMed
    Score: 0.040
  40. B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of women. J Am Coll Cardiol. 2014 Oct 28; 64(17):1789-97.
    View in: PubMed
    Score: 0.038
  41. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet. 2015 Jan 24; 385(9965):351-61.
    View in: PubMed
    Score: 0.038
  42. Comparison of lifestyle-based and traditional cardiovascular disease prediction in a multiethnic cohort of nonsmoking women. Circulation. 2014 Oct 21; 130(17):1466-73.
    View in: PubMed
    Score: 0.038
  43. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet. 1994 Apr 16; 343(8903):940-3.
    View in: PubMed
    Score: 0.037
  44. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 1993 May 08; 341(8854):1165-8.
    View in: PubMed
    Score: 0.034
  45. Plasma adiponectin and the risk of hypertension in white and black postmenopausal women. Clin Chem. 2012 Oct; 58(10):1438-45.
    View in: PubMed
    Score: 0.033
  46. Comparison of delay times to hospital presentation for physicians and nonphysicians with acute myocardial infarction. Am J Cardiol. 1992 Jul 01; 70(1):10-3.
    View in: PubMed
    Score: 0.033
  47. The primary prevention of myocardial infarction. N Engl J Med. 1992 May 21; 326(21):1406-16.
    View in: PubMed
    Score: 0.032
  48. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor. Circulation. 1992 May; 85(5):1822-7.
    View in: PubMed
    Score: 0.032
  49. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012 Mar 31; 379(9822):1205-13.
    View in: PubMed
    Score: 0.032
  50. The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study. Am Heart J. 1991 Dec; 122(6):1588-92.
    View in: PubMed
    Score: 0.031
  51. Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapy. Circulation. 1991 Aug; 84(2):708-11.
    View in: PubMed
    Score: 0.031
  52. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. Ann Intern Med. 1991 May 15; 114(10):835-9.
    View in: PubMed
    Score: 0.030
  53. Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women. Clin Chem. 2011 May; 57(5):729-36.
    View in: PubMed
    Score: 0.030
  54. Hemoglobin A1c, body mass index, and the risk of hypertension in women. Am J Hypertens. 2011 Mar; 24(3):328-34.
    View in: PubMed
    Score: 0.029
  55. Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med. 1990 Dec; 89(6):772-6.
    View in: PubMed
    Score: 0.029
  56. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation. 1990 Sep; 82(3):897-902.
    View in: PubMed
    Score: 0.029
  57. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J Am Coll Cardiol. 2010 May 25; 55(21):2319-27.
    View in: PubMed
    Score: 0.028
  58. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women. Diabetes Care. 2009 Jan; 32(1):3-8.
    View in: PubMed
    Score: 0.025
  59. Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial. Diabetes Care. 2008 Dec; 31(12):2338-43.
    View in: PubMed
    Score: 0.025
  60. Genetic variation of the androgen receptor and risk of myocardial infarction and ischemic stroke in women. Stroke. 2008 May; 39(5):1590-2.
    View in: PubMed
    Score: 0.024
  61. Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. Metabolism. 2008 Mar; 57(3):437-43.
    View in: PubMed
    Score: 0.024
  62. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol. 2007 Dec 01; 100(11):1654-8.
    View in: PubMed
    Score: 0.024
  63. Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. Clin Chem. 2007 Oct; 53(10):1749-56.
    View in: PubMed
    Score: 0.023
  64. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes. 2007 Jul; 56(7):1898-904.
    View in: PubMed
    Score: 0.023
  65. C-reactive protein in the prediction of rheumatoid arthritis in women. Arch Intern Med. 2006 Dec 11-25; 166(22):2490-4.
    View in: PubMed
    Score: 0.022
  66. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism. 2006 Nov; 55(11):1473-80.
    View in: PubMed
    Score: 0.022
  67. A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women. Cancer Res. 2006 Mar 01; 66(5):2869-75.
    View in: PubMed
    Score: 0.021
  68. Hemoglobin A1c concentrations and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):3010-2.
    View in: PubMed
    Score: 0.021
  69. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. Ann Epidemiol. 2006 Feb; 16(2):105-12.
    View in: PubMed
    Score: 0.020
  70. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005 Jul 06; 294(1):47-55.
    View in: PubMed
    Score: 0.020
  71. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005 Jul 06; 294(1):56-65.
    View in: PubMed
    Score: 0.020
  72. Association between consumption of beer, wine, and liquor and plasma concentration of high-sensitivity C-reactive protein in women aged 39 to 89 years. Am J Cardiol. 2005 Jul 01; 96(1):83-8.
    View in: PubMed
    Score: 0.020
  73. Aspirin and cardiovascular disease prevention in women: new findings from the Women's Health Study. Womens Health (Lond). 2005 Jul; 1(1):9-10.
    View in: PubMed
    Score: 0.020
  74. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005 Jun; 28(6):1438-44.
    View in: PubMed
    Score: 0.020
  75. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation. 2005 May 17; 111(19):2446-53.
    View in: PubMed
    Score: 0.020
  76. Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med. 2004 Apr 12; 164(7):757-61.
    View in: PubMed
    Score: 0.018
  77. Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS). Circulation. 2004 Apr 06; 109(13):1623-9.
    View in: PubMed
    Score: 0.018
  78. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation. 2003 Oct 07; 108(14):1688-93.
    View in: PubMed
    Score: 0.018
  79. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002 Apr 11; 346(15):1113-8.
    View in: PubMed
    Score: 0.016
  80. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation. 1997 Mar 04; 95(5):1132-7.
    View in: PubMed
    Score: 0.011
  81. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996 May 02; 334(18):1145-9.
    View in: PubMed
    Score: 0.011
  82. Discrimination in absorption or transport of beta-carotene isomers after oral supplementation with either all-trans- or 9-cis-beta-carotene. Am J Clin Nutr. 1995 Jun; 61(6):1248-52.
    View in: PubMed
    Score: 0.010
  83. Height and incidence of cardiovascular disease in male physicians. Circulation. 1993 Oct; 88(4 Pt 1):1437-43.
    View in: PubMed
    Score: 0.009
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.